At-a-Glance:
| Company |
Chongqing Biospes Co., Ltd |
|---|
| Specialties |
Antibodies, ELISA kits, Assay kits, Recombinant and native proteins, Assistive reagents, WB reagents, PCR-related reagents |
|---|
| Mission |
To provide the global research community with high-quality, rigorously validated biological reagents that support robust and reliable experimental outcomes. |
|---|
| Noteworthy |
Backed by years of market validation and ongoing product refinement, Biospes' ELISA kit portfolio has been expanded with new additions—one-step ELISA, small-molecule ELISA, and HiLAKit—to accommodate a wider array of customer research needs. |
|---|
| Location |
Chongqing, China |
|---|
Established in 2012, Chongqing Biospes Co., Ltd is a manufacturer and supplier of high-quality biological reagents for life science research. The company has been recognized as a Chinese National High-Tech Enterprise and holds 16 registered trademarks, 7 national patents, and 1 software copyright.
Biospes’ founders have extensive backgrounds in life science and biotechnology, and are committed to ensuring the company delivers the finest research tools to scientists worldwide. The company also prides itself on its stringent quality standards and ongoing product refinement.
The company’s product line includes multiple categories of antibodies—among them in vivo monoclonal antibodies, small molecule antibodies, loading control and tag antibodies, and SARS-CoV-2 antibodies—along with recombinant and native proteins, PCR-related reagents, and assay kits such as Annexin V apoptosis kits and matched antibody pairs. Biospes describes this offering as a "full-chain product matrix" spanning basic research through clinical translation.
Biospes also offers a comprehensive range of ELISA kits with complete indicator coverage and broad species reactivity, spanning multiple research fields including cytokines, inflammatory factors, neurobiology, signaling pathways, tumor markers, immunology, and infectious diseases. Backed by years of market validation and ongoing product refinement, the company’s ELISA kit portfolio has been expanded with new additions—one-step ELISA, small-molecule ELISA, and HiLA Kit—to accommodate a wider array of customer research needs.
Biospes’ products are exported to more than 20 countries and regions, and it has long-term relationships with research institutions both in China and internationally. The company’s customer base includes research reagent distributors, OEM resellers, and scientific researchers. Biospes offers “full-process service” including technical consultation, solution design, and after-sales support and reports that is consistently has industry-leading customer satisfaction.
Looking ahead, the company has identified two priorities: expanding its product matrix with more specialized reagents for clinical translation and drug development, and further building out its global service network and distribution channels through partnerships with distributors and research institutions in additional countries and regions. Biospes also has several technical projects as well as innovative reagents to better serve global customers in the pipeline.